← Back to Search

Visual feedback of symptom frequency for Bulimia

N/A
Waitlist Available
Led By Michele M Laliberte, Ph.D.
Research Sponsored by St. Joseph's Healthcare Hamilton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
BMI (Body Mass Index) over 19
Diagnosis of Bulimia Nervosa, Binge Eating Disorder, or Other Specified Feeding and Eating Disorder (OSFED) Purging Disorder.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at week 6, 10, and up to 25 weeks (end of group treatment)
Awards & highlights

Study Summary

This study is evaluating whether providing visual graphs of eating disorder symptoms in the early sessions of treatment will lead to higher rates of rapid response in patients with eating disorders.

Eligible Conditions
  • Bulimia
  • Binge Eating Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at week 6, 10, and up to 25 weeks (end of group treatment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at week 6, 10, and up to 25 weeks (end of group treatment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in eating disorder symptoms from baseline
Secondary outcome measures
Eating Disorders

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Visual feedback of symptom frequencyExperimental Treatment1 Intervention
Participants in this arm receive visual feedback of their symptom frequency over the first 4 weeks of active treatment, based on information they provide on a symptom checklist.
Group II: No visual feedback of symptom frequencyActive Control1 Intervention
Participants in this arm complete the symptom checklist as is typically done during treatment, but receive no visual feedback of their self-reported symptom frequency over the first 4 weeks of active treatment.

Find a Location

Who is running the clinical trial?

St. Joseph's Healthcare HamiltonLead Sponsor
195 Previous Clinical Trials
25,344 Total Patients Enrolled
1 Trials studying Bulimia
160 Patients Enrolled for Bulimia
Michele M Laliberte, Ph.D.Principal InvestigatorSt. Joseph's Healthcare Hamilton

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Mar 2025